Losada-Díaz Federico, Lizarazo-Bocanegra Santiago, Perdomo-Lugo Juan J, Gutiérrez-Romero Sebastián A, Correa-Osio Isabella, Mendivil Carlos O
School of Medicine, Universidad de los Andes, Bogotá, Colombia.
Section of Endocrinology, Department of Internal Medicine, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Diabetes Ther. 2024 Nov;15(11):2279-2291. doi: 10.1007/s13300-024-01646-y. Epub 2024 Sep 14.
Obesity is both a major risk factor for diabetes and a serious comorbidity of the condition. The twin epidemics of obesity and diabetes have spread globally over the past few decades. Treatment of obesity in patients with diabetes provides a host of clinical benefits that encompass virtually all body systems. Despite this, multiple lines of evidence suggest that the efficacy of most therapies for weight loss is significantly reduced among patients with diabetes. With this background, we summarize the evidence of a differential effect of lifestyle, pharmacological, and surgical treatments for obesity in patients with existing diabetes, and explore the potential mechanisms involved in this phenomenon. This information is then used to formulate strategies to improve weight loss outcomes for patients with diabetes.
肥胖既是糖尿病的主要危险因素,也是该疾病的严重合并症。在过去几十年中,肥胖和糖尿病这两大流行疾病已在全球蔓延。糖尿病患者的肥胖治疗带来了一系列临床益处,几乎涵盖所有身体系统。尽管如此,多项证据表明,对于糖尿病患者,大多数减肥疗法的疗效会显著降低。在此背景下,我们总结了生活方式、药物和手术治疗对现有糖尿病患者肥胖的不同影响的证据,并探讨了这一现象背后的潜在机制。然后利用这些信息制定策略,以改善糖尿病患者的减肥效果。